BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3988370)

  • 1. Inhibition of growth of certain human tumour cell lines by a factor derived from human fibroblast-like cell lines. I. Demonstration by mixed culture and by use of cell washings.
    Wu KF; Pope JH; Ellem KA
    Int J Cancer; 1985 Apr; 35(4):477-82. PubMed ID: 3988370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Discovery and demonstration of the tumor growth inhibitor derived from human fibroblast-like cell lines].
    Wu KF; Pope JH; Ellem KA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):1-6. PubMed ID: 2954683
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines.
    Tani A; Tatsumi E; Nakamura F; Kumagai S; Kosaka Y; Sano K; Nakamura H; Amakawa R; Ohno H
    Leukemia; 1996 Oct; 10(10):1592-603. PubMed ID: 8847894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiated fibroblasts protect Burkitt lymphoma cells from apoptosis by a mechanism independent of bcl-2.
    Falk MH; Hültner L; Milner A; Gregory CD; Bornkamm GW
    Int J Cancer; 1993 Sep; 55(3):485-91. PubMed ID: 8397166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
    Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
    Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice.
    Gurtsevitch VE; O'Conor GT; Lenoir GM
    Int J Cancer; 1988 Jan; 41(1):87-95. PubMed ID: 2826348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Partial purification and characterization of the tumor growth inhibitor derived from human fibroblast-like cell lines].
    Wu KF; Sculley TB; Pope JH; Ellem KA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):7-12. PubMed ID: 2954694
    [No Abstract]   [Full Text] [Related]  

  • 8. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
    Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
    Int J Cancer; 1984 Sep; 34(3):339-48. PubMed ID: 6090321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines.
    Mouzakiti A; Packham G
    Br J Haematol; 2003 Jul; 122(1):61-9. PubMed ID: 12823346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
    Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
    Orlowski RZ; Eswara JR; Lafond-Walker A; Grever MR; Orlowski M; Dang CV
    Cancer Res; 1998 Oct; 58(19):4342-8. PubMed ID: 9766662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line.
    Finerty S; Rowe M; Berry PJ; Ranson DL; Mott MG; Gregory CD; Rickinson AB
    Br J Cancer; 1986 Sep; 54(3):385-91. PubMed ID: 3019376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines.
    Epstein AL; Kaplan HS
    Cancer Res; 1979 May; 39(5):1748-59. PubMed ID: 371794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
    Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
    Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the incorporation of bromodeoxyuridine by human lymphoblastoid cell lines.
    Henderson EE; Strauss B
    Cell; 1975 Aug; 5(4):381-7. PubMed ID: 1157096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and biological nature of established human hematopoietic cell lines.
    Nilsson K; Pontén J
    Int J Cancer; 1975 Feb; 15(2):321-41. PubMed ID: 165156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.
    Favrot MC; Philip I; Philip T; Portoukalian J; Doré JF; Lenoir GM
    J Natl Cancer Inst; 1984 Oct; 73(4):841-7. PubMed ID: 6592381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.